baber/WOPTO huggingface dataset:
Patent EP-0630248-B1 (EP)
Inventor: ELGER WALTER
IPC: A61K9/70
Filed: 1993-03-18
Granted: 1998-10-14
Abstract: PCT No. PCT/EP93/00636 Sec. 371 Date Aug. 31, 1994 Sec. 102(e) Date Aug. 31, 1994 PCT Filed Mar. 18, 1993 PCT Pub. No. WO93/18774 PCT Pub. Date Sep. 30, 1993The invention relates to the use of estriol as the sole active ingredient for the production of a transdermal medicament which continuously releases the active ingredient for the treatment of climacteric osteoporosis. It has been shown according to the invention that estriol, which has up until now been thought ineffective for the treatment of climacteric osteoporosis, develops strong anti-osteoporotic effectiveness upon continuous transdermal application.
Patent EP-0660716-B1 (EP)
Inventor: WOODWARD DAVID F
IPC: C07C247/10
Filed: 1993-09-09
Granted: 2001-11-28
Abstract: The present invention provides cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives, substituted in the 1-position with halo, methyl, hydroxyl, nitro, amino, amido, azido, oxime, cyano, thiol, either or thioether groups, e.g., a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives. The cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives of the present invention are potent ocular hypotensives, and are particularly suitable for the management of glaucoma. Moreover, the cyclopentane heptanoic, 2-(cycloalkyl or arylalkyl) derivatives of this invention are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases; smooth muscle relaxants with application in gastrointestinal disease, reproduction, fertility, incontinence, shock, etc.
Patent EP-0666904-B1 (EP)
Title: Souches affaiblies d'aeromonas salmonicida utilisees comme vaccins pour poissons
Inventor: THORNTON JULIAN C
IPC: C12N1/20
Filed: 1993-10-04
Granted: 1997-12-29
Abstract: L'invention se rapporte à de nouvelles souches affaiblies d'Aeromonas Salmonicida agissant efficacement comme vaccins vivants contre la furonculose chez les poissons. Ces vaccins peuvent être administrés par immersion des poissons dans une solution du vaccin. Des procédés de production de ces souches, ainsi que d'autres souches présentant les caractéristiques d'identification de ces souches sont également décrits.
Patent EP-0635746-B1 (EP)
Inventor: SIMIONI LUCIANO
IPC: A61F9/02
Filed: 1994-07-18
Granted: 1999-03-10
Abstract: Multilayer lens particularly usable for sunglasses, having a main layer (2) made of polycarbonate, cellulose acetate, or similar materials. A mirror reflecting layer (4) is possibly coupled to the main layer or deposited thereon in vacuum by sublimation of appropriate substances, with the optional interposition of a layer of paint (3). The multilayer lens furthermore includes an outer layer (5) that partially affects the outer surface of the lens. The lens may also include an inner antifogging layer (9) that does not absorb moisture. This multilayer lens allows optimum vision to the user, eliminating or attenuating spurious incident rays at the lateral ends of the lens. <IMAGE>
Patent EP-0646672-B1 (EP)
Inventor: MAGEE WALTER L
IPC: B60R21/235
Filed: 1994-08-25
Granted: 1996-11-06
Abstract: Fabrics coated with an organopolysiloxane composition containing (a) an organopolysiloxane having aliphatic unsaturation, (b) an organohydrogenpolysiloxane having SiH groups in which the silicon to hydrogen ratio is from 10:1 to 1:1, (c) a catalyst which is capable of promoting the addition of SiH groups to the aliphatically unsaturated groups, (d) a hydrophobic silica filler, (e) a flame retardant and optionally an adhesion promoting agent. The coated fabric can be used in manufacturing air bags for automobiles.
Patent EP-0626573-B1 (EP)
Inventor: DRUBETSKY EMIL
IPC: G01L21/14
Filed: 1994-03-15
Granted: 1998-01-07
Abstract: A thermocouple vacuum gauge includes a first thermocouple element spaced below a second thermocouple element. The two thermocouples are electrically connected in series in a back-to-back manner by connecting together their respective negative ends. A pulse generator supplies a pulsing on-off current only to the first thermocouple. During the off intervals, a thermally generated voltage signal is measured between the positive ends of the thermocouples and compared to a reference signal. The result of the comparison is used to vary the output current of the pulse generator. The amount of current supplied sufficient to cause the measured voltage signal to approach the reference signal is proportional to the amount of pressure or vacuum in an enclosure in which the thermocouples are placed.
Patent EP-0622769-B1 (EP)
Inventor: LEWINER JACQUES
IPC: G08G1/123
Filed: 1994-04-28
Granted: 1999-08-04
Abstract: The invention relates to a portable box (1) intended to inform the users of an omnibus network of the waiting times for omnibuses at the various stops of this network. Simple actuations of keys (3, 4, 5), translated by appropriate displays on a screen (2) of the box, make it possible to store several bus journeys in this box, which terminate respectively at predetermined stops of the network, and simply pressing on a button (6 or 7) allows selective display on the said screen of any one of the stored journeys, with visual information on the waiting times for buses at the stop at which this journey terminates. <IMAGE>
Patent EP-0661460-B1 (EP)
Inventor: JEANTIL ROBERT
IPC: F15B11/20
Filed: 1994-12-22
Granted: 1998-04-22
Abstract: Device for the hydraulic regulation of the rotation of two shafts driven respectively by a first hydraulic motor and a second hydraulic motor (20, 18) supplied with hydraulic fluid from a common source to which they are connected in series by means of respective directional control valves (21, 25), characterised in that the downstream terminal of the first hydraulic motor (20) is connected to the downstream terminal of the second hydraulic motor (18) by means of a sequential valve (28) set for a predetermined pressure value and connected to the upstream terminal of the first motor (20) and designed, by opening, to cause the second motor to stop when the pressure on the upstream terminal of the first motor reaches the said predetermined value. <IMAGE>
Patent EP-0688320-B1 (EP)
Inventor: HOHLWEG ROLF
IPC: A61P25/24
Filed: 1994-02-18
Granted: 1999-05-06
Abstract: Tricyclic benzazepines having the general formula nd  beta -marked carbon atoms is a cyclopentene, cyclohexene, furan, dihydrofuran, pyran, dihydropyran, thiophene, oxazole, pyrrole, pyrroline, tetrahydropyridine or dioxole ring, R1 is H or alkyl, R2 and R3 independently are H, alkoxy, halogen, nitro, cyano or hydroxy, or R2 and R3 together may form a furan, dihydrofuran, cyclopentene or dioxole ring and R4 is H, alkoxy, nitro, cyano, hydroxy or halogen, or a pharmaceutically acceptable salt thereof, are useful in treatment of certain disorders in the central nervous system, e.g., psychosis, pain, depression, sleep disturbances, dyskinesia, Parkinson's disease, stroke.
Patent EP-0672611-B1 (EP)
Inventor: HARTWIG MARKUS DIPL-ING
IPC: B66F9/07
Filed: 1995-02-16
Granted: 1999-09-22
Abstract: The shelf stacking vehicle (4) for loading and unloading shelves has a drive system consisting of running wheels arranged behind one another, underneath a loading hoist (10). The hoist has a platform (6) for pallets and containers, which can elevate and lower, and can pivot about an axis. When negotiating curved paths through shelf systems, the hoist can also rotate so as to follow the direction of the shelving. The hoist can also be arranged to be coaxial to the axis of rotation (11a,11b) and/or the pivot of at least one running wheel (9a).
Patent EP-0693254-B1 (EP)
Inventor: NEUMANN HERMANN DR
IPC: A01N53/06
Filed: 1995-07-04
Granted: 2001-10-24
Abstract: Gel formulation (A) for evapn. systems to provide controlled and long-lasting release of insecticide, comprises at least one pyrethroid insecticide (I), at least one evaporation regulator (II), and an inorganic solid (III) as gelling agent. Specified (I) are 2,3,5,6-tetrafluorobenzyl (+)1R-trans-2,2-dimethyl- 3-(2,2- dichlorovinyl)cyclopropane carboxylate (Ia, esp.); and 2,2-dimethyl-3-(2-methylpropenyl)-cyclopropane carboxylic acid 2-methyl-3-propargyl-4-oxo-2-cyclopenten-1-one ester etc.. Esp. gel is present in a deep-drawn or cast container of plastic or metal, closed at the top with a fabric or foil that is permeable to volatile components.
Patent EP-0698684-B1 (EP)
Inventor: EHROLA JUHA
IPC: F16C13/00
Filed: 1995-07-25
Granted: 2001-11-28
Abstract: The invention concerns a variable-crown roll loaded by means of shoes, comprising a stationary roll axle (12), around which a tubular roll mantle (11) is fitted revolving, which roll mantle is mounted by its ends on the roll axle (12) by means of end bearings (13a,13b). Hydraulic loading shoes (151...15n) are fitted between the roll mantle (11) and the roll axle (12), which shoes act upon the inner face of the roll mantle (11) in the nip plane and are supported on the roll axle (12) and which shoes are loaded by means of a hydraulic pressure medium, and the nip pressure can be profiled in the axial direction of the roll (10) by regulating the pressure of the pressure medium passed into said loading shoes. The roll mantle (11) is made of a fibre-reinforced composite material so that the stability of shape of the roll mantle (11) in the direction of the circumference is good and the rigidity in the axial direction is low. <MATH>
Patent EP-0709678-B1 (EP)
Inventor: ISHIKAWA EIJI
IPC: B01L3/00
Filed: 1995-10-25
Granted: 2001-01-24
Abstract: An immunoassay plate for an immune complex transfer immunoassay, comprising a well type solid phase and a dip stick type solid phase which can be inserted into said well type solid phase, wherein the dip stick type solid phase is coated with either substance (A) or (B) to be mentioned below and the well type solid phase is coated with the other, remaining substance, and these solid phases are used as the two solid phases to be used for an immune complex transfer immunoassay:   (A): a substance having a reactive group which specifically binds to a functional group previously introduced onto a substance, which specifically forms an immune complex with a test substance (B): a substance having a reactive group capable of specifically binding to the test substance in the immune complex, a substance which specifically forms an immune complex with the test substance, or a functional group conjugated in advance with said substance, provided that the moiety which binds to the reactive group of (A) does not bind to the reactive group of (B) and vice versa. According to the present invention, an immune complex transfer immunoassay can be markedly simplified. Consequently, a highly sensitive immune complex transfer immunoassay can be conducted with ease and with high precision. <IMAGE>   <IMAGE>
Patent EP-0725794-B1 (EP)
Inventor: ROLLINS BARRETT
IPC: C12N5/10
Filed: 1994-11-07
Granted: 2001-08-22
Abstract: The invention relates to a human MCP-1 derivative, and pharmaceutical compositions thereof, wherein human MCP-1 has been modified such that the protein inhibits monocyte chemoattractant activity. Successful inhibition of the activity is found where the MCP-1 is modified in one or more of the following: a) the 28-tyrosine is substituted by aspartate, b) the 24-arginine is substituted by phenylalanine, c) the 3-aspartate is substituted by alanine, and/or d) the 2-8 amino acid sequence is deleted. The claimed MCP-1 derivatives can be administered to a patient in need of inhibiting MCP-1 monocyte chemoattractant activity. For example, the derivatives can be used to prevent restenosis, such as that which is common in a patient undergoing coronary artery angioplasty. The invention further relates to compositions and methods of inhibiting monocyte chemoattractant activity of MCP-1 employing the derivatives described.
Patent EP-0745000-B1 (EP)
Inventor: HILLS ROBIN WILLIAM
IPC: B05B12/24
Filed: 1995-02-14
Granted: 2001-04-25
Abstract: The sealing strip comprises an elongate sealing portion (7) formed of resiliently compressible material such as foam and an elongate attachment portion (8) extending laterally from the sealing portion (7). The attachment portion is provided with adhesive (2) to affix it to the rear side of a first body panel (9) so that the sealing portion (7) is located in a gap between the panel (9) and an adjacent component (10) so as to seal or mask the gap therebetween. The sealing portion and attachment portion are preferably integrally formed by an extrusion process. The sealing strip has particular application to the sealing of the "B" post gap of a motor vehicle. <IMAGE>
Patent EP-0743933-B1 (EP)
Inventor: MAHLER BARRY ASHER
IPC: C07C19/08
Filed: 1995-02-06
Granted: 1999-06-09
Abstract: L'invention a pour objet un procédé de séparation du pentafluoroéthane d'un mélange de pentafluoroéthane et de chloropentafluoroéthane, au moyen d'agents d'extraction tels que, entre autres, un hydrochlorocarbure, un hydrocarbure et des chlorocarbures.
Patent EP-0746501-B1 (EP)
Inventor: JAGGER THEODORE W
IPC: B65B55/02
Filed: 1995-02-27
Granted: 2001-07-04
Abstract: Apparatus for filling sterile containers is disclosed which defines an elongated but narrow sterile zone in which a number of operating stations are disposed. An elongated vertical wall is carried by an elongated frame and a cabinet type enclosure cooperates with the vertical wall to define the sterile zone. The plurality of operating stations are disposed in sequential relation over the length of the sterile zone, and an elongated container conveyor is disposed within the sterile zone to convey the containers through the plurality of operating stations. The conveyor is vertically oriented, consisting an endless belt mounted on end wheels that rotate on horizontal axes. Each of the operating stations includes an operating portion disposed within the sterile zone. Actuating means are included for each of the operating stations as well as the elongated conveyor, each of which is disposed outside the sterile zone. Connecting means operabably connect each of the actuating means outside the sterile zone through the vertical wall to the associated operating station within the sterile zone. By orienting the conveyor vertically and disposing the various actuating means outside the sterile zone in side-by-side relation, the effective width of the sterile zone is significantly reduced. As a result, the sterile zone is more easily accessed, and also more easily drained after washdown operations. In addition, the sterile zone of reduced size results in an apparatus that much easier to manufacture and maintain in a sterile state.
Patent EP-0750706-B1 (EP)
Inventor: PRUSS DONALD E
IPC: E04B2/86
Filed: 1995-03-14
Granted: 1999-12-22
Abstract: There is disclosed a monolithic unit having spaced apart panels (12, 14) for concrete walls in which the unit includes in one embodiment tie members (40) having a chemically similar polymeric composition to that of the panels (12, 14) but differing in a physical form. The result is a fusibly connected integral unit.
Patent EP-0762840-B1 (EP)
Title: Ensemble repose-poignet
Inventor: WOLF ROBERT J
IPC: G06F3/02
Filed: 1995-04-21
Granted: 1998-09-16
Abstract: Ensemble repose-poignet (10) destiné à être utilisé le long du bord avant d'un périphérique prévu pour être mis en ÷uvre par les mains ou les doigts d'une personne, à l'avant d'un clavier (11) d'ordinateur par exemple, cet ensemble repose-poignet comprenant une base allongée (14) sur laquelle repose un coussin allongé (17) formé d'une enveloppe contenant une couche de gel (19). Le coussin est suffisamment épais entre ses surfaces supérieure et inférieure et suffisamment large entre ses bords pour pouvoir supporter un poignet d'utilisateur sur la surface supérieure sous laquelle se situe une partie de la couche de gel et pour se conformer aux poignets supportés, et pour permettre à la surface supérieure du coussin sur laquelle reposent le(s) poignet(s) de se déplacer sur une distance notable par rapport à la surface inférieure dans un plan globalement parallèle à la surface supérieure de la base. Cette base présente des parties supérieure et inférieure respectivement prévues pour supporter le coussin et pour être supportées sur une surface horizontale; ainsi qu'une structure qui permet à la partie supérieure d'être supportée sur la partie inférieure avec la surface supérieure du coussin située à une distance prédéterminée, sélectionnée parmi plusieurs distances différentes, au-dessus de ladite surface horizontale.
Patent EP-0835500-B1 (EP)
Inventor: COLLINS DEBORAH LYNN
IPC: G09B5/06
Filed: 1995-05-24
Granted: 2000-08-16
Abstract: A method and apparatus is provided for automated learning and performance evaluation of a group of items by a user. The method, which can be practised on a digital computer, has steps of querying the user as to whether items are believed to be known or unknown, sorting the items into groups of perceived known and unknown items and generating a sequence of items to be displayed. The apparatus e.g. a digital computer, has input means for receiving a user's response, a display means for presenting the material to be learned and logic means for sorting the items. An important feature of this invention is that the user is tested regarding his belief as to whether the item is known or unknown, not as to his actual knowledge.
Patent EP-0767771-B1 (EP)
Inventor: JORGE EDWARD M
IPC: C01B11/06
Filed: 1995-05-24
Granted: 1998-12-30
Abstract: L'invention concerne un procédé de préparation de chlorhydrines par réaction d'un produit de chloration, tel qu'un acide hypochloreux, avec au moins un composé organique insaturé, tel que propylène ou butylène, à un pH supérieur à 6. On obtient le produit de chloration dans une première étape par réaction d'une source de chlore, telle que Cl2 gazeux, avec une source aqueuse d'ajustement de pH, telle que NaOH aqueux.
Patent EP-0769951-B1 (EP)
Inventor: PATTERSON ALAN
IPC: A61K47/10
Filed: 1995-07-05
Granted: 2003-09-10
Abstract: An injectable composition of higher residual effect with reduced detrimental effects such as pain at injection site, swelling, tissue irritancy or necrosis and containing as active principle a tetracycline compound, either as the free base or a salt thereof with a physiologically acceptable acid, complexed with a substantially equimolar amount of a magnesium compound, is solubilised in a water miscible solvent system comprising, either (i) a) glycerol formal in an amount of from about 10 to about 50 % v/v; with b) polyethylene glycol in an amount of from about 1 to 15 % v/v; or (ii) from about 25 to about 75 % v/v of N-methylpyrrolidone, said composition optionally containing a pH modifier in an amount sufficient to maintain a physiochemically acceptable pH, the balance being made up with water q.s.
Patent EP-0775184-B1 (EP)
Inventor: ZIEMER JAMES N
IPC: B01J29/16
Filed: 1995-06-20
Granted: 2004-11-03
Abstract: A process is provided for producing a high quality lubricating oil base stock with a catalyst having a high viscosity index selectivity and low fouling rate. The catalyst contains a low amount of zeolite, and has a pore size distribution characterized by a significant amount of large pores.
Patent EP-0717789-B1 (EP)
Title: Compositions and methods for treating cleaning solvents
Inventor: KIANY ESFANDIAR
IPC: C11D7/24
Filed: 1995-07-06
Granted: 1999-09-22
Abstract: A solvent composition for parts cleaning is improved by addition of an additive composition comprising at least one aromatic, aliphatic or alkaryl sulfonic acid or salt thereof or an esterified polyol or an alkyl phenol formaldehyde resin which has been modified to include alkoxy solubilizing groups. The additive composition provides agglomeration and accelerated settling of contaminant particles in the solvent cleaning composition.
Patent EP-0775557-B1 (EP)
Inventor: NAKAGAWA HITOSHI
IPC: G05B19/4067
Filed: 1995-07-31
Granted: 1998-09-23
Abstract: A normal operating condition restoration device which comprises: (a) taught point memory means for storing successive taught points that constitute a work line on which a tool travels in relation to a workpiece and storing taught points for retraction which are among the taught points constituting the work line and to which the tool can be retracted from the workpiece; (b) tool abnormality detecting means for detecting abnormal conditions which have occurred in the tool traveling on the work line relative to the workpiece; and (c) controlling means for performing control such that upon detection of occurrence of abnormal conditions in the tool by the tool abnormality detecting means, the tool is shifted from an abnormality occurring point to the nearest taught point for retraction, following back a path on the work line which the tool has already passed, according to point information stored in the taught point memory means so that the abnormal tool is retracted from the workpiece, and such that a new tool or repaired tool is then brought to the abnormality occurring point by way of the above path on the work line to be installed thereat. <IMAGE>   <IMAGE>
Patent EP-0802979-B1 (EP)
Inventor: BURKE RAE LYN
IPC: C12Q1/70
Filed: 1995-07-21
Granted: 2008-01-09
Abstract: The present invention relates generally to modified secreted viral proteins, to the genes which express these proteins and to antibodies produced against such proteins, and to the use of these materials in diagnostic and vaccine applications. In particular, the present invention describes deletion of the transmembrane region only and retention of at least part of the cytoplasmic domain itself or fusion with at least part of an alternate cytoplasmic domain. The result will generally be the secretion of proteins which are normally membrane-bound (nonsecretory). This invention greatly increases the efficiency of secretion of the derivative protein. Specific viral proteins of interest include, but are not limited to, those from CMV, HSV, EBV, VZV, HCV, HIV, and influenza.
Patent EP-0785781-B1 (EP)
Inventor: GUPTA PAUL
IPC: A61P3/04
Filed: 1995-10-05
Granted: 2001-12-19
Abstract: The invention provides the use of a compound formula (I) wherein R1 and R2 independently represent H or C1-C6 alkyl, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment of: dermatological disorders; peripheral neuropathies; arthritis; gastrointestinal or urogenital disease; headache associated with substances or their withdrawal; tension headache; pediatric migraine; post-traumatic dysautonomic cephalgia; orofacial pain; allergic or chronic obstructive airways diseases, glaucoma or ocular inflammation; or prophylaxis of migraine
Patent EP-0787032-B1 (EP)
Title: Assembly for processing a fluid by filtration and centrifugation
Inventor: CHRISTOPHE THEOPHILE
IPC: B04B1/02
Filed: 1995-10-19
Granted: 1999-12-22
Abstract: PCT No. PCT/FR95/01382 Sec. 371 Date Sep. 3, 1996 Sec. 102(e) Date Sep. 3, 1996 PCT Filed Oct. 19, 1995 PCT Pub. No. WO96/12549 PCT Pub. Date May 2, 1996The invention relates to a fluid treatment assembly comprising a filter (4) which itself comprises filtering elements (5) and a cleaning device (12) for periodically cleaning each filtering element including a conduit (17) for the evacuation of the cleaning fluid filled with impurities resulting from the cleaning, the treament assembly further comprising a centrifuging device which itself comprises a rotary enclosure (37) connected to a fluid admission conduit (28). According to the invention, the filtering elements (5) and the enclosure (37) are contained in a single casing (1A-1B), while the admission conduit (28) is directly connected (29-30) to the conduit (17) for evacuating the cleaning fluid. The invention finds an application in the construction of a compact and reliable assembly.